RB Global: The Sell-Off Looks Overdone; We Stay Buy

RB Global reported Q2 revenue up 11%, but adjusted EBITDA increased only 6%, with operating leverage pressured by lower take rates and acquisition mix. The company highlighted continued share gains in Automotive GTV and a reinforcing nationwide insurer relationship for its physical marketplace infrastructure. BigIron expansion into a large agriculture transaction market adds a new cross-selling avenue, supporting longer-term platform growth despite near-term margin headwinds.

Analysis

The key issue is not top-line growth but the conversion of that growth into cash earnings. When revenue outpaces EBITDA by this much, the market starts questioning whether the platform is getting more transactional but less monetizable, which usually compresses the multiple before it shows up in consensus estimates. The risk is that lower take rates are not a one-quarter noise item but a sign that RB Global is paying up for growth via mix shift, acquisitions, or competitive pricing in higher-frequency categories.

Competitive dynamics look more nuanced than the headline suggests. The insurer relationship and auto share gains reinforce that RB Global has real distribution power, but that also implies the company is increasingly competing on service breadth rather than pure auction economics, which can cap near-term margin expansion. BigIron is strategically interesting, but agriculture is a slower-turning, more fragmented market with potentially lower monetization initially; the first-order effect may be TAM expansion, while the second-order effect is dilution of consolidated margins until cross-sell and integration synergies are proven.

Over the next 1-3 months, the stock is likely to trade on whether management can stabilize take rate and show that acquisition mix normalizes. Over 6-18 months, the bull case is that RB Global becomes a broader asset-disposition platform with durable network effects; the bear case is that it becomes a larger but lower-margin roll-up. What would falsify the bearish view is evidence of EBITDA margin reacceleration despite continued GMV share gains; what would falsify the bull case is another quarter where revenue growth materially exceeds EBITDA growth and guidance does not call for margin recovery.

Key Decisions for Investors

• Do not chase RBA on the print; wait 1 quarter for proof that take-rate pressure is stabilizing. If adjusted EBITDA continues to lag revenue by >300 bps next quarter, expect further multiple compression and treat rallies as sellable.
• For a medium-term entry, buy RBA only on a post-earnings de-rating if management signals margin normalization within 1-2 quarters. The risk/reward improves if the market is pricing the company like a low-margin roll-up rather than a platform business.
• Use CPRT as a relative-value hedge only if subsequent disclosures show RB Global is taking share in auto/insurance workflows faster than expected. Otherwise, avoid forcing a short in CPRT; its quality premium can stay intact even if RB improves.
• Set a watch item on BigIron integration and ag cross-sell. If the segment adds volume without lifting consolidated EBITDA margins over the next 2-3 quarters, the strategic expansion is likely overearning its premium in the stock.